Skip to Content

PureVax Feline 3/Rabies (Canada)

This page contains information on PureVax Feline 3/Rabies for veterinary use.
The information provided typically includes the following:
  • PureVax Feline 3/Rabies Indications
  • Warnings and cautions for PureVax Feline 3/Rabies
  • Direction and dosage information for PureVax Feline 3/Rabies

PureVax Feline 3/Rabies

This treatment applies to the following species:
Manufacturer: Merial

Feline Rhinotracheitis-Calici-Panleukopenia-Rabies Vaccine

Modified Live Virus, Canarypox Vector

(RCP/rRabies-SWD)

DESCRIPTION: PUREVAX® Feline 3/Rabies contains a nonadjuvanted lyophilized suspension of modified live feline rhinotracheitis, calici, and panleukopenia viruses; recombinant vectored rabies vaccine; plus a sterile water diluent. A canarypox vector has been modified, using recombinant technology, to produce expression of desired antigens capable of stimulating a protective immune response to rabies. Safety and immunogenicity of this product have been demonstrated by vaccination and challenge studies in susceptible cats.

INDICATIONS: PUREVAX® Feline 3/Rabies is recommended for the vaccination of healthy cats 8 weeks of age or older for prevention of disease due to feline rhinotracheitis, calici, panleukopenia, and rabies viruses.

DOSAGE: Reconstitute the lyophilized vaccine with accompanying liquid diluent and aseptically inject 1 mL (1 dose) subcutaneously into healthy cats. For primary vaccination of cats younger than 12 weeks of age, revaccinate every 3 to 4 weeks with the last dose given at or over 12 weeks of age. For primary vaccination of cats 12 weeks or older, revaccinate with a second 1 ml dose of this product or Code 16D8.21 (Purevax® Feline 3), 3 to 4 weeks later. Revaccinate annually with a single 1 mL dose.

PRECAUTIONS: Store at 2-7°C (35-45°F). Use immediately after reconstitution. Do not use chemicals to sterilize syringes and needles. Burn this container and all unused contents. Contains gentamicin as a preservative. Do not vaccinate pregnant cats. In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine.

SOLD TO VETERINARIANS ONLY.

Store at 2-7°C (35-45°F).

For Veterinary Use Only.

PUREVAX is a registered trademark of MERIAL.

Manufactured By MERIAL INC., Athens, GA 30601 USA

U.S. Vet. Lic. No. 298

1-888-Merial-1 (1-888-637-4251)

Distributed In Canada By MERIAL CANADA, INC., Baie d’Urfé, (Québec), H9X 4B6, Canada

Contains

 

Prod. No.

 

25 Doses

25 x 1 Dose, Lyophilized

25 x 1 mL, Sterile Water

2132-25

RM820R6

NAC No.: 11820513

MERIAL CANADA INC.
20000 CLARK GRAHAM, BAIE D'URFÉ, QC, H9X 4B6
Telephone:   514-457-1555
Order Desk:   888-637-4251 (888-MERIAL1)
Fax:   514-457-1175
Website:   www.merial.ca
Email:   service.canada@merial.com
Every effort has been made to ensure the accuracy of the PureVax Feline 3/Rabies information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2016 North American Compendiums. Updated: 2016-08-21

Hide